Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exploring Innovations in SPR & Combination Screening

Published: Tuesday, August 26, 2014
Last Updated: Wednesday, August 27, 2014
Bookmark and Share
Genedata customers will discuss innovations in high content imaging, high throughput screening, compound combination screening, and other related topics at User Group Meetings.

Scientists from AstraZeneca, Chugai Pharmaceutical, Sanford-Burnham Medical Research Institute, and UT Southwestern Medical Center will be among Genedata customers discussing innovations in high content imaging, high throughput screening, compound combination screening, and other related topics    

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the Genedata Screener® Global User Group Meetings will be held in Asia, Europe, and North America during September 2014. Screening experts from global pharmaceutical companies and leading research organizations will gather for annual User Group Meetings to share best practices, case studies, and upcoming challenges in all areas of screening. This year's sessions will also showcase enhancements and new functionality in the recently released Genedata Screener version 12, which includes data analysis capabilities for Surface Plasmon Resonance (SPR), Thermal Shift, as well as Combination and Panel Screens.
 
Most of the world's leading pharmaceutical companies, academic institutions, and contract research organizations rely on Genedata Screener as their single computational platform for all plate-based screening. Genedata Screener users from AstraZeneca, Chugai Pharmaceuticals, Sanford-Burnham Institute, and University of Texas Southwestern Medical Center will be among the speakers presenting their research work using Genedata Screener. Featured sessions will explore topics such as:  
 
•    application of high content imaging and stem cells within phenotypic drug discovery;
•    identification of novel natural products and synthetic molecules for treatment of lung cancer; and
•    best practices for applying Genedata Screener in a variety of screening environments.
 
"Screener User Group Meetings bring together many of the world's thought leaders in the application of screening technologies in pharmaceutical R&D," said Dr. Othmar Pfannes, CEO of Genedata. "We are proud to host these annual events, which provide forums in which scientists can share their experiences in advancing scientific progress with Genedata Screener -- the most comprehensive computational platform for screening worldwide."
 
Genedata Screener User Group Meetings are held regionally throughout the world so that customers can easily access and participate in these knowledge-sharing events. Meetings for 2014 will be held in: Tokyo, Japan (Sept. 4); Basel, Switzerland (Sept. 9-10); Boston, MA (Sept.16); and San Francisco, CA (Sept. 18).






Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genedata Releases a Breakthrough for Genomic Comparison
Genedata Selector™4.0 provides reference-independent genome sequence comparisons while reducing data processing and analysis time to optimize efficiency and save costs.
Wednesday, July 22, 2015
Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
Genedata Expressionist® for Genomic Profiling helps Takara Bio to manage, process, and analyze large NGS datasets.
Wednesday, November 05, 2014
Takeda Selects Genedata Expressionist for Genomic Profiling
Takeda Pharmaceutical expands use of Genedata Expressionist by adding solution for next-generation sequencing data analysis.
Friday, July 13, 2012
Genedata Unveils New Japanese Web Site for Expanding Pharma R&D and Life Science Business
New web site closely follows an expansion of Genedata in Japan and supports the growing customer base in Asia.
Monday, November 16, 2009
Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Personalized Medicine
Genedata Phylosopher® and Expressionist® biomarker discovery platforms to be integrated into TcLand Expression’s computational infrastructure.
Thursday, April 09, 2009
Genedata and FRISYS Turn Over new Leaf in Systems Biology Collaboration
Within the FRISYS framework, Genedata`s Phylosopher system has been applied to integrate public, experimental and in-licensed data.
Thursday, May 08, 2008
Genedata Provides Expressionist Platform to U.S. Food and Drug Administration
Genedata Expressionist is a computational platform for biomarker discovery that integrates transcriptomics, proteomics and metabolomics data within a single enterprise software system.
Thursday, November 29, 2007
Genedata Joins Japanese Research Initiative for Metastatic Biomarkers
Genedata collaborates with Tokyo Medical University, AMR Inc., and Leica Microsystems in a proteomics research initiative.
Wednesday, November 14, 2007
Genedata Provides Data Management and Analysis Platform for System Biology Initiative FRISYS
Both the experimental and theoretical FRISYS research groups will use central data management and analysis platform provided by Genedata.
Tuesday, July 10, 2007
Genedata Opens Subsidiary in Tokyo
Genedata’s new offices based in Japan will provide local support for life sciences research with a focus on pharmaceutical research.
Wednesday, June 27, 2007
Genedata Expands Collaboration with HepatoSys
Swiss-based computational biology provider Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network.
Friday, February 09, 2007
Genedata Joins Industry-Academic Systems Biology Consortium
The consortium exploits experimental and computational methods to probe the biological mechanisms underlying industrial fermentation.
Friday, November 10, 2006
Genedata Collaborates with HepatoSys Systems Biology Competence Network
Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.
Monday, July 10, 2006
Genedata Collaborates with €12.6M European Cancer Research Consortium
Company will provide research informatics for the consortium’s efforts to improve cancer diagnosis and treatment.
Wednesday, June 28, 2006
GeneData Enters License Agreement with Wyeth

Thursday, October 17, 2002
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!